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1. Introduction
  Periodontitis is a chronic inflammatory disorder affecting 
the supporting tissues of teeth. The pathogenesis of 
periodontitis involves the interaction between periodontal 
pathogens and host inflammatory and immune responses. 
Cytokines play a critical role in mediating inflammatory 
processes and tissue homeostasis underlying periodontitis. 
Extensive research has been conducted to demonstrate the 
expression and changes of various kinds of cytokines in 
normal periodontal tissues and pathological conditions[1,2]. 
  Of the cytokines that are implicated in the development of 
periodontitis, it is unclear how exactly IFN-毭 participates 
in periodontal tissue destruction. IFN-毭 is secreted by 
Th1 cells and induces IL-1毬, TNF-毭 and prostaglandin 
E2 (PGE2) production by macrophages. Therefore, it is 
proinflammatory in nature. However, IFN-毭 also inhibits 
osteoclastogenesis by interfering with the RANKL-RANK 
signaling pathway[3], suggesting that it may serve a dual 
function. In contrast, IL-10 is thought to be an anti-
inflammatory cytokine and suppresses immune and 
inflammatory responses[4]. The expression profile of IL-10 
in healthy and diseased periodontal conditions has yet to 
be elucidated. IL-17 has recently received broad attention 
for its role in periodontal tissue destruction. Considered 
a proinflammatory cytokine and secreted by CD4 Th17 
cells, IL-17 has been found to be involved in a number of 
systemic conditions, including rheumatoid arthritis and 
several autoimmune disorders. However, studies have 
reported varying results concerning levels of IL-17 in 
Objective: To evaluate the correlation of chronic periodontitis in tropical area and IFN-毭, IL-10 
and IL-17 levels. Methods: One hundred and forty-eight patients and one hundred and thirty-
two healthy control subjects were included in the study. Clinical parameters (PI, GI and PD) and 
GCF levels of IFN-毭, IL-10 and IL-17 were measured at baseline, week 8, week 16 and week 
24 after mechanical removal of dental plaque. IFN-毭 and IL-10 were determined with ELISA 
methods and IL-17 was determined with the cytometric bead array. Results: Removal of dental 
plaque resulted in improvement in all clinical parameters. Meanwhile, GCF IL-17 declined to 
control levels, while GCF IFN-毭 and IL-10 levels remained unchanged. Conclusions: The 
decline of GCF IL-17 levels in patients with resolution of periodontitis suggests that IL-17 is 
involved in the periodontal inflammatory process.
 Qi-Ya Fu et al./Asian Pacific Journal of Tropical Medicine (2013)489-492490
Gingival crevicular fluid (GCF) and in periodontal tissues[5,6]. 
The present study was carried out to investigate GCF levels 
of IFN-毭, IL-10 and IL-17 in both healthy and diseased 
periodontal states in a tropical population.
  
2. Materials and methods
2.1. Patient recruitment and study protocol
  All 148 patients with chronic periodontitis admitted from 
November 2010 to May 2012 were selected. In addition, 132 
periodontally healthy individuals were assigned into the 
control group. The vast majority of the patients and healthy 
controls were natives of Hainan, a tropical island in southern 
China. Informed consent was acquired from each participant 
prior to recruitment. Patients meeting the following selection 
criteria were randomly admitted into the research project: (1) 
the subject was a nonsmoker between 35-60 years of age; (2) 
there was no systemic infection, diabetes, immunodeficiency 
disorder and autoimmune disease; (3) no periodontal therapy 
of any form had been provided and no antibiotics, nonsteroid 
antiinflammatory drugs and glucocorticoids had been taken 
in the preceding six months; (4) the selected tooth had a 
periodontal pocket measuring between 4-6 mm.
  For each patient or control subject, four periodontal sites 
from four different quadrants were selected. Baseline 
measurements, consisting of clinical parameters and GCF 
samples, were taken before mechanical removal of dental 
plaque was initiated. Clinical parameters included plaque 
index (PI) (Silness and L觟e, 1964)[7], gingival index (GI) 
(L觟e and Silness, 1963)[8] and probing depth (PD), and GCF 
samples were determined for GCF volume, IFN-毭, IL-10 
and IL-17 levels. After baseline measurements, each patient 
received oral hygiene instructions, supragingival scaling 
and root planing, while control subjects received only oral 
hygiene instructions. The same measurements were taken at 
week 8, week 16 and week 24, respectively. 
  
2.2. GCF collection
  Before GCF collection, the teeth were isolated with cotton 
rolls and supragingival plaque was removed with a scaler, 
which was kept clear of gingiva. For each tooth, GCF was 
obtained at the junction of the buccal and mesial surfaces. 
A Periopaper襆 (Oraflow Inc., NY, USA) strip was gently 
inserted into the gingival sulcus until slight resistance was 
encountered. After 30 seconds, the strip was withdrawn 
and GCF volume was measured using Periotron (Model 
8000, Oraflow, NY, USA) calibrated with a 0.01 M sodium 
phosphate buffer. The sample was then placed in a 1.5 mL 
micro centrifuge tube containing 150 毺L PBS-Tween 20 
(0.1M PBS, 0.05% Tween 20, pH 7.4) and stored at -70 曟 until 
cytokine quantification. Strips contaminated with blood were 
discarded and samples were re-collected at a later time.
2.3. Quantification of GCF IFN-毭, IL-10 and IL-17 levels
  IFN-毭 levels in the GCF samples were determined with an 
IFN-毭 ELISA kit by Millipore (Millipore Corporation, MA, 
USA); the levels of IL-10 were determined with a cytometric 
bead array kit (BD Bioscience-Pharmingen, CA, USA); and 
the levels of IL-17 were measured with a Human IL-17 
ELISA (Quantikine R&D Systems, MN, USA). All the assays 
were conducted according to manufacturers’ instructions. 
2.4. Statistical analysis
  Data analysis was performed using the statistical package 
SPSS version 14.0. Values are expressed as the mean依SD. 
Data from the chronic periodontitis groups and the control 
groups were compared at each time point. Student t-tests 
were used where appropriate. P < 0.05 was considered 
statistically significant.
3. Results
  The chronic periodontitis group included 76 male and 72 
female patients, with a mean age of 43.8依5.51, while the 
control group had 68 male and 64 female subjects, with a 
mean age of 41.3依5.06. GCF volumes were much higher at 
chronic periodontitis sites than at periodontally healthy 
control sites (P < 0.01). After mechanical removal of dental 
plaque, there was a sharp decline in GCF volume. However, 
the GCF volumes remained higher at week 8, week 16 and 
week 24 when compared with those at healthy sites (P < 0.05) 
(Table 1). 
  Mechanical plaque removal led to marked improvement 
in all clinical parameters. At week 8, mean PI, GI and PD 
scores all showed significant decrease. From week 8 to 
week 24, the chronic periodontitis group’s PI scores were 
on longer significantly different from those of the control 
group. In contrast, the patients’ GI scores remained slightly 
higher than the healthy controls’ scores (P < 0.05) (Table 
2). Both before and after dental plaque removal, GCF IFN-
毭 levels were not statistically different between the two 
groups, although mean values for the chronic periodontitis 
group seemed slightly higher at all time points (Table 3). A 
similar pattern could be seen for IL-10 (Table 3). GCF IL-17 
levels in the chronic periodontitis group was higher than in 
the control group at baseline, but at subsequent time points, 
there was no difference between the two groups (Table 3).
Table 1
Influence of periodontal basic therapy on GCF volume (mean依SD)       (
毺/L).
Group Baseline Week 8 Week 16    Week 24
Periodontitis 0.153依0.068** 0.063依0.016* 0.076依0.015* 0.067依0.018*
Control 0.036依0.009 0.023依0.007 0.032依0.006 0.031依0.008
*P < 0.05, ** P < 0.01 compared with controls.
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Table 2
Effect of periodontal basic therapy on clinical parameters (mean依SD) 
(毺/L).
Group Baseline Week 8 Week 16    Week 24
Periodontitis PL 2.12依0.52** 1.09依0.34 0.91依0.27 0.93依0.25
GI 2.33依0.57** 0.63依0.16* 0.68依0.19* 0.64依0.18*
PD 4.88依0.62** 3.59依0.43** 3.36依0.40** 3.39依0.38**
Control PL 1.08依0.35 0.87依0.23 0.78依0.29 0.84依0.19
GI 0.40依0.15 0.36依0.11 0.39依0.13 0.42依0.16
PD 0.77依0.21 0.76依0.20 0.77依0.19 0.75依0.18
*P < 0.05, ** P < 0.01 compared with controls.
Table 3
Effect of periodontal basic therapy on IFN-毭, IL-10 and 
IL-17 (mean依SD) (pg/mL).
Group Baseline Week 8 Week 16    Week 24
Periodontitis IFN-毭   0.26依0.13   0.20依0.15   0.24依0.16   0.22依0.19
IL-10 16.10依5.40 13.20依4.70 14.80依5.00 12.90依4.60
IL-17   4.60依1.39**   2.69依1.10   2.65依1.40   2.58依1.30
Control IFN-毭   0.19依0.14   0.16依0.11   0.18依0.13   0.17依0.10
IL-10 12.60依4.90 11.80依4.30 13.50依4.40 12.10依4.20
IL-17   2.10依0.87   2.34依1.00   2.46依1.20   2.32依1.10
** P < 0.01 compared with controls.
4. Discussion
  In this study, we analyzed GCF IFN-毭, IL-10 and IL-17 
levels in patients with chronic periodontitis both before and 
following mechanical dental plaque removal. Accompanying 
overall improvement in clinical measurements, IL-17 
levels showed decline after plaque removal. However, 
no change seems to have occurred in GCF IFN-毭 and 
IL-10 levels. Previous studies on these cytokines have 
generated conflicting and sometimes confusing data. Our 
results are largely in agreement with those from a study 
by Zhao et al, in which GCF IL-17 and IL-21 levels were 
decreased and IFN-毭 levels were unchanged in a group of 
Chinese periodontitis patients after receiving periodontal 
treatment[9]. It needs to be pointed out that our subjects 
represent a tropical population in southern China. One 
study on an Indian population failed to detect IL-17 in 
GCF[10]. It is not clear whether regional alone can adequately 
account for the discrepancy. Most studies have also been 
unable to find any difference in GCF IFN-毭 levels after 
resolution of periodontal inflammation[11]. Experimental 
studies have demonstrated that IFN-毭 positive cells such 
as Th1 cells play a prominent role in mediating periodontal 
tissue destruction, although detailed processes still need 
to be revealed[12]. In addition to the three cytokines, a 
number of other proinflammatory cytokines, such as IL-1毩, 
IL-1毬, IL-6, IL-8 and TNF-毩, have been shown to be 
closely involved in the pathogenesis of periodontal disease. 
There is a positive correlation between periodontal disease 
activity and tissue cytokine levels[13,14]. Host responses 
mediated by cytokines are believed to be essential in the 
breakdown of connective tissue and bone, which is the key 
feature of the disease process.
  For a long time, our understanding of T helper cell-
mediated immunity was based on the Th1/Th2 model. 
According to this model, Th1 cells, which secret IL-2 and 
IFN-毭, are responsible for cell-mediated responses, such 
as inflammatory processes, while Th2 cells, producing 
IL-4, IL-5 and IL-13, lead to humoral immune responses, 
including allergic reactions[15]. The identification of the Th17 
subset has brought about a new perspective on immune 
mechanisms involved in inflammatory disorders. Th17 cells 
produce IL-17, IL-22, IL-26 and IL-21. IL-17 is capable of 
stimulating a variety of cell types to produce inflammatory 
mediators such as IL-1, IL-6, TNF-毩, metalloproteinases, 
and chemokines. Th17 cells are crucial in immune responses 
against extracellular bacteria[16]. They also participate in 
the pathogenesis of several autoimmune and inflammatory 
disorders. It has been shown that IL-17A produced by 
Th17 cells promotes the development of osteoclasts when 
osteoblasts are present[17]. In addition, IL-17 is expressed 
at gingival sites in patients with periodontitis[18]. As our 
data show, GCF IL-17 levels in patients with periodontitis 
are much higher than in healthy subjects. Furthermore, IL-
17 expression has been observed in the alveolar bone of 
patients with chronic periodontitis[18]. It has been recently 
demonstrated that levels of IL-21 in gingival tissues 
are increased in patients with chronic periodontitis[19]. 
Therefore, all lines of evidence point to the involvement 
Th17 cells and their cytokines in the pathogenesis of 
periodontal disease.
  In the present study, resolution of periodontal inflammation 
was achieved exclusively with mechanical dental plaque 
removal. The significant improvement in patients’ 
periodontal conditions had been expected. In the past three 
decades, a large number of studies have clearly shown that, 
in many cases, nonsurgical therapy can be a valid alternative 
to surgical therapy[20,21]. It seems that outcomes of treatment 
modalities are to a large extent dependent on the probing 
depth. In shallow periodontal pockets (1-3 mm), nonsurgical 
therapy results in 0.3 mm less clinical attachment loss than 
surgical therapy. There is also less probing depth reduction 
(about 0.1 mm). In pockets ranging from 4-6 mm, nonsurgical 
therapy results in 0.3 mm more clinical attachment gain but 
0.3 mm less probing depth reduction than surgical therapy. 
For pockets deeper than 6 mm, surgical therapy shows an 
advantage in probing depth reduction[22,23]. There is no 
statistically significant difference in clinical attachment 
level gain between treatment modalities. Where long-term 
treatment outcomes are concerned, no significant difference 
between treatment modalities has been found for shallow 
pockets. However, surgery provides a greater reduction in 
probing depth for pockets exceeding 4 mm[24,25]. Since our 
primary objective was to examine the relationship between 
clinical periodontal health status and GCF cytokine levels, 
no attempt was made to compare the effectiveness of 
different treatment modalities.
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  In conclusion, after resolution of periodontal inflammation, 
clinical parameters improved significantly and GCF IL-
17 levels in patients with chronic periodontitis declined 
accordingly. In contrast, GCF IFN-毭 and IL-10 levels 
remained largely unchanged. The results suggest that IL-17 
is involved in the periodontal inflammatory process.
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